Results 171 to 180 of about 24,424 (206)

Advances in Understanding and Management of Myeloproliferative Neoplasms

Ca-A Cancer Journal for Clinicians, 2009
Paola Guglielmelli
exaly  

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

Cancer Cell, 2005
Jan Cools, Benjamin L Ebert, Gerlinde Wernig   +2 more
exaly  

Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk‐stratification and management

American Journal of Hematology, 2020
Ayalew Tefferi, Tiziano Barbui
exaly  

Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

New England Journal of Medicine, 2015
Alessandro Maria Vannucchi, Martin Griesshammer, Tamás Masszi   +2 more
exaly  

Polycythemia (Excluding Polycythemia Vera)

2020
openaire   +1 more source

Polycythemia Vera

JAMA: The Journal of the American Medical Association, 1990
openaire   +2 more sources

Vascular and Neoplastic Risk in a Large Cohort of Patients With Polycythemia Vera

Journal of Clinical Oncology, 2005
Roberto Marchioli, Raffaele Landolfi, Heinz Gisslinger   +2 more
exaly  

Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

New England Journal of Medicine, 2013
Roberto Marchioli, Giorgina Specchia, Valerio De Stefano   +2 more
exaly  

Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia

Nature Genetics, 2002
Kiichi Hirota, Enli Liu, Patrick H Maxwell   +2 more
exaly  

A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis

Leukemia, 2017
Francesco Passamonti, Toni Giorgino, Paola Guglielmelli   +2 more
exaly